Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15112948
Abstract: Despite the recent approval of novel immunotherapies, such as immunomodulatory drugs, proteasome inhibitors and anti-CD38 monoclonal antibodies, Multiple Myeloma (MM) remains incurable, and the acquisition of triple-refractoriness leads to really dismal outcomes in even earlier… read more here.
Keywords: real life; clinical trials; mafodotin clinical; belantamab mafodotin ... See more keywords